chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Eczema on hands and feet after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (Eczema on hands and feet after 2nd shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 040E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced ECZEMA (Eczema on hands and feet after 2nd shot). At the time of the report, ECZEMA (Eczema on hands and feet after 2nd shot) outcome was unknown.            No any concomitant medications were reported. No any treatment medications were reported.  Patient noticed eczema on hands and feet a week after the second shot.
2 days after my first vaccine I developed diarrhea.  I have had diarrhea for 3 months now
Patient is a male and was in excellent health prior to the following events. Patient reports development of left shoulder severe pain 3 hours after 2nd injection of Moderna vaccine on May 21, 2021. The shoulder pain never dissipated. and continued for the next year. Pt reports having headaches starting 3 hours after vaccine. Headaches continued through June, July, August and Sept 2021 intermittently. In October 2021, headaches became severe. In December 2021, pt sought medical care and was diagnosed with Migraine headaches. Headaches continued in 2022.   On May 30, 2022 he felt poor, and could barely move shouldersed . Patient went to medical multiple times. On May 31, pt experienced an episode of altered mental status and was taken to the Emergency room. Patient was admitted to both cardiology and neurology. EEG showed abnormal background slowing. Brain MRI showed chronic anterior cerebrovascular ischemia, likely serving as an epileptic focus. He had bradycardia with pulse 18-30. Working diagnsosis "sick sinus syndrome", causing watershed ischemic cerebral event. A pacemaker was placed, which patient still has.  Patient has had three seizures since, with the last event causing a dislocated shoulder during the fall. Brain MRI June 2022 showed chronic ischemic change of basal ganglia and extending to right parietal lobe. Pt has negative coagulopathy workup, negative ANA, no vasculitis on CT angiography of head neck.    Patient will be medically separated for this event.
A few hours after admin immunization pt c/o intense pain in all joints, HA, muscle cramps x 24 hours. no fever, no local reaction, no local pain at site of injection.
Patient states he had a flare of joint pain symptoms in 2004 that lasted most of the year after receiving the anthrax vaccine series and the smallpox vaccine in the latter part of 2003. He went on to be diagnosed with ankylosing spondylitis in 2007.
Headache after dose; This is a spontaneous report received from non-contactable reporter(s) (Other HCP) from a sales representative.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, bnt162b2 omi ba.4-5 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache after dose".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Fever, chills, migraine headache, fatigue, numbness in left leg from knee to foot, nausea. Symptoms lasted for 8 days before subsiding.
(between elbow and vaccination spot) spot; (between elbow and vaccination spot) red; (between elbow and vaccination spot) itchy; (between elbow and vaccination spot) swelled up; Slight fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.     This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight fever), VACCINATION SITE PAIN ((between elbow and vaccination spot) spot), VACCINATION SITE ERYTHEMA ((between elbow and vaccination spot) red), INJECTION SITE PRURITUS ((between elbow and vaccination spot) itchy) and VACCINATION SITE SWELLING ((between elbow and vaccination spot) swelled up) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (Slight fever). On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN ((between elbow and vaccination spot) spot), VACCINATION SITE ERYTHEMA ((between elbow and vaccination spot) red), INJECTION SITE PRURITUS ((between elbow and vaccination spot) itchy) and VACCINATION SITE SWELLING ((between elbow and vaccination spot) swelled up). At the time of the report, PYREXIA (Slight fever), VACCINATION SITE PAIN ((between elbow and vaccination spot) spot), VACCINATION SITE ERYTHEMA ((between elbow and vaccination spot) red), INJECTION SITE PRURITUS ((between elbow and vaccination spot) itchy) and VACCINATION SITE SWELLING ((between elbow and vaccination spot) swelled up) outcome was unknown.
pt recv vax & became preg LMP9/8/97;estimated date of delivery 6/15/98;11/24/97 & 1/21//98 pt exp spotting;
The patient had 2 doses of Pfizer COVID-19 vaccine as part of staffing vaccination.  About 2 weeks ago her adult son, who lives with her, tested positive for COVID-19. Patient had some vague sinus congestion symptoms but has environmental allergies and frequently has such symptoms. She was reassured that since she had been fully vaccinated, this was likely the case, but decided she needed to be tested to be sure (facility has worked to keep  COVID out). On 2/26/21 she tested positive for COVID by antigen test. On same day she had PCR test, but no results yet. Except for some voice loss and sinus congestion, no other symptoms.
While administering vaccination, the needle popped off of the syringe barrel (wasn't screwed on tight) and the vaccine shot out of the barrel. It is unknown the dose the patient actually received.
I had chest pain and shortness of breath. I was diagnosed with pericarditis after needing to go to the emergency room. It has been 5 months since my vaccine and I am still suffering.
Patient presented to ED with chief complaint of sudden onset dizziness, epigastric pain and generalized weakness, symptoms happened the day before yesterday, resolved, she noticed when she is trying to do any activities she gets heart fluttering. Epigastric pain noted in ED.  Troponin Elevated, heparin IV started for possible NSTEMI. Patient is currently admitted.
Chest pain, 4/10 "tight"; started upon waking up the morning of 12/31 - between 36-48hrs post injection. VS stable - normal oxygen and HR no murmurs on exam no reproducible pain
Pediarix was administered inadvertently instead of Kinrix for final DTap and IPV in series. Mom reports child doing well; no adverse side effects.
My eye is swollen, just my right eye; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 (Lot number: FC3181) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Verbatim: Blood pressure. Concomitant medication(s) included: LISINOPRIL. Vaccination history included: Bnt162b2 (Dose 1, Anatomical site of vaccination: Left arm, Lot Number: FA7484), for Covid-19 Immunization. The following information was reported: EYE SWELLING (non-serious) with onset 15Aug2021, outcome "not recovered", described as "My eye is swollen, just my right eye". Therapeutic measures were not taken as a result of eye swelling.  Additional Information: Patient took low dose of Blood Pressure medication. The patient had not received any other vaccine within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Initially after vaccine I had sore arm but that went away by third day. Yesterday I woke up and notice my left armpit has a large lump and very sore along with left side of my left breast is extremely tender. Hurts to put my arm down by my side.  It?s been over a week since I had my first dose and just now started yesterday so I don?t know if related.  Will make an appointment for breast exam this week because I?m scared that left side of my left breast suddenly hurts and my left armpit visibly much bigger than right like there?s a knot in it
Headache, fatigue, body aches, shivering, and stomach upset lasting 2 days
Rapid heart beat; My heart keeps beating kind of fast and it has been going on for like two hours; Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-9 VACCINE), administration date 09Mar2021 10:50 (Batch/Lot number: unknown) at the age of 72 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing), notes: on medication; "allergic to Lysol Spray" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE; LOSARTAN; ATENOLOL. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 09Mar2021, outcome "unknown", described as "Sore arm"; HEART RATE INCREASED (non-serious) with onset 09Mar2021 22:00, outcome "recovering", described as "Rapid heart beat; My heart keeps beating kind of fast and it has been going on for like two hours". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, heart rate increased.  Additional information: The patient's concomitant medications AMLODIPINE; LOSARTAN; ATENOLOL; all taken for an unspecified indication, start and stop dates were not reported. The course of the events was as follows: Patient had her first shot today and she did not know if she was experiencing a side effect or what was going on with her. Patient had the shot around, her appointment was at 10:50 am this morning and she felt okay around the day. Patient just had like a sore arm and around 10 o' clock this evening, she started getting like rapid heart beat and it went on until 11 to 11:30 and that is when she decided to call out. The only thing she did out of ordinary was she did not want them to spray, she was allergic to Lysol Spray. She was allergic to Lysol Spray the spray that you use to kill germs. Patient had a technician who came to fix the TV so when he left, due to COVID, she decided to use the spray. Patient left her home and was gone for three hours she waited and that was the only thing she did out of the ordinary because she did not want to use the spray. So, that was what confusing her and that was why she called because her heart keeps beating kind of fast and it has been going on for like two hours now and she decided she would call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
expired dose administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number FS734, expiry date 21st January 2022) for prophylaxis.   On 26th January 2022, the patient received the 2nd dose of Boostrix. On 26th January 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The reporter reported a patient was administered an expired dose of the Boostrix vaccine inadvertently in the left deltoid, which led to expired vaccine used. The reporter consented to follow up. The case has been linked to US2022014888, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022014888:Same reporter
everytime I get the shot, I am sicker than a dog; Initial information received on 01-Nov-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (consumer) via social media.  This case is linked to cases 2020SA308140, 2020SA307964 and 2020SA308037.  This case involved a patient of an unknown age and gender who every time got the shot, patient was sicker than a dog (Illness), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, it was reported that every time the patient got shot, the patient was sicker than a dog (Illness).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome was reported as unknown for the event of illness.  There will be no information available on the batch number for this case.
developed a rash in my back and groin that did not go away; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received the second dose of bnt162b2 (Lot number was not reported), via an unspecified route of administration in the left arm on 10Feb2021 09:30 AM (at the age of 67-year-old) at single dose for COVID-19 immunization. Medical history included anxiety and some lactose intolerance. Concomitant medications included venlafaxine; fluoxetine hydrochloride (PROZAC); azelastine hydrochloride, fluticasone propionate (DYMISTA); amlodipine; and atorvastatin calcium (ATORVAS).  The patient previously took lisinopril and experienced drug allergy. The patient previously received the first dose of bnt162b2 via an unspecified route of administration on the left arm on 22Jan2021 09:30 AM (at the age of 67-year-old) at single dose for COVID-19 immunization. Approximately 5 days after receiving the 2nd Covid 19 vaccine on 15Feb2021 12:00, the patient developed a rash in his back and groin that did not go away until 3 days ago when he was prescribed Prednisone 20 mg (2 a day) by an allergist. Prior to the Prednisone the rash was very persistent and increasing in intensity. The patient didnot know if it had to be with the vaccine, but five days later and did not respond to antihistamines or over the counter ointments for rash. No covid prior vaccination nor covid tested post vaccination. The event resulted in Emergency room/department or urgent care. The outcome of the event was unknown.    Information on Lot/Batch number has been requested.
no additional AE; Caller reports patient was administered VARIVAX and PROQUAD at same office visit.  No other information provided.  No additional AEs or PQC reported.; interchange of vaccine products; Information has been received from a pharmacist, referring to 4 years-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On 28-SEP-2023, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), 0.5 milliliter,  lot #W035466, expiration date: 06-MAY-2024, administered subcutaneously in the Right thigh for prophylaxis (strength was not provided); additional, the patient also received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #W025277, expiration date: 10-AUG-2024, administered in Left thigh for prophylaxis (strength, and route of administration were not provided).  The reporter said that the nurse made the mistake as she thought that measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was the same as Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). No additional adverse events were reported.
Several hours post vaccine patient reporting light dry cough, runny nose, shortness of breath at rest. Took 50 mg PO diphenhydramine and symptoms resolved within 45 minutes.
On 10/23/18 I began to have numbness and tingling in both my feet. It progressed up to my knees and then up to my hips. I was unable to feel when I was urinating or moving my bowels. I was admitted to the hospital on 10/28/18 and was discharged on 11/29/18. I was diagnosed with Transverse Myelitis. I was treated with high dose steroids intravenously with no improvement. I then received 7 treatments of plasmapheresis after which I developed Heparin Induced Thrombocytopenia. My platelets were normal on admission at 240,000 and I have never had any issues with my platelets. When I was discharged my platelets were still low and the numbness and tingling in my legs was improving and now remains just from my knees down.
Headache, Arthralgia, RHINORHEA, SNEEZING, SORE THROAT, NASAL CONGESTION, FATIGUE, CHILLS PAIN/SWELLING INJ SITE Narrative:  Other Relevant History:
had reactions to the Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (had reactions to the Moderna Covid-19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (had reactions to the Moderna Covid-19 vaccine). At the time of the report, IMMUNISATION REACTION (had reactions to the Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.  The reporter reported that the reporter knew of a patient who had reactions to the Moderna Covid-19 vaccine.
HEADACHE; TIRED; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cerebral venous sinus thrombosis, diabetic, and non smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient experienced drug allergy when treated with estradiol, and progesterone.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAR-2021, the subject experienced injection site pain. On 16-MAR-2021, the subject experienced headache. On 16-MAR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain on 19-MAR-2021, and tired on 26-MAR-2021, and was recovering from headache. This report was non-serious.
Post day 2  injection site sore;day 3-5 HA/Nausea,Day 7 TIA hosp with 2 TIAs Day 8
Redness and tenderness at site of vaccination. Vaccine given 10/1/14 symptoms started on evening of 10/02/14.
I have been throwing up; This is a spontaneous report from a Pfizer sponsored program . A female patient of unspecified age (consumer) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/LOT no unknown) dose 1 on unspecified date and second dose on 10Feb2021 via an unspecified route of administration as single dose for COVID-19 immunisation. The medical history and concomitant medication were not provided. Patient reported she just wanted to talk to somebody. Patient needed to start over with her situation she had been throwing up. patient needed to find out if this was related to vaccine. Patient was having an adverse reaction last 14Feb2021 and 19Feb2021. Product details (Lot, Expiration Date, NDC and UPC) and other consumer details could not be probed. Medical information had been requested. The outcome of the event was unknown.  No follow up attempts are possible. No further information is expected.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. No medical history or concurrent conditions were reported. On 20-MAR-2012, patient was vaccinated with the first dose of GARDASIL. (Dose, strength and route not provided). Co-suspect or concomitant therapies were not reported. On 11-MAR-2014, patient received the second dose of GARDASIL. No adverse event reported. Additional information is not expected.
Onset approximately 10 days after shot with fever to 101.7 and rash.
Information has been received from a licensed practical nurse concerning a 7 year-old male patient with no pertinent medical history and no known drug reactions or diagnosed allergies who on 10-Dec-2002 was vaccinated with a first dose OKA/MERK (no lot# provided) at another office. On 04-May-2007 the patient was vaccinated with a second dose of JERYL LYNN (+) WISTAR RA 27/3 (+) OKA/MERK upgrade process (lot # 552295/0250U valid for VAQTA, MSD). There was no concomitant medication. On 28-Dec-2008 the patient developed chickenpox. Patient sought medical attention by going to an office visit. No lab diagnostic studies performed. Patient was told to use BENADRYL, TYLENOL and AVEENO bath. At the time of the report the patient had not recovered. Follow-up information was received from the licensed practical nurse. It was reported that patient had rash on face, neck and trunk, pimples, vesicle lesions, lesions with scabs. Patient had treatment with BENADRYL and TYLENOL and on an unspecified date he recovered. No further information is available.
Approximately a week after receiving the J&J injection I have experienced excessive itching in the areas of my abdomen, groin, inguinal and femoral lymph nodes. There are no rashes, sores, or other visible marks associated with the itching sensation.
tingling around the bottom lip; tingling around the chin area; This case was reported by a consumer via call center representative and described the occurrence of tingling lips in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced tingling lips and tingling skin. On an unknown date, the outcome of the tingling lips and tingling skin were unknown.   It was unknown if the reporter considered the tingling lips and tingling skin to be related to Shingrix.     Additional Information: GSK Receipt Date: 8-Aug-2022 Reporter's comment: The patient self reported the case. The patient received a dose of Shingrix about 2 months ago and got tingly bottom lip and chin. The reporter wanted to know if the Shingrix vaccine caused it. Follow up was not possible as no contact details were available.